Clinical implications of residual sleep apnoea after chronic CPAP therapy

J. Verbraecken

Source: Breathe 2011; 7: 289-290
Journal Issue: March

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Verbraecken. Clinical implications of residual sleep apnoea after chronic CPAP therapy. Breathe 2011; 7: 289-290

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002

Compliance in sleep apnoea therapy: influence of home care support and pressure mode
Source: Eur Respir J 2009; 33: 804-811
Year: 2009



Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Objective compliance with oral appliance therapy versus CPAP in moderate obstructive sleep apnea
Source: International Congress 2017 – CPAP therapy
Year: 2017


The role of bi-level therapy in obstructive sleep apnoea
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008


Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014


Long-term CPAP compliance in women with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Empirical Auto-CPAP therapy for diagnosis of sleep apnoea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 417s
Year: 2001

Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007